Effects of polyaspartic acid on pharmacokinetics of tobramycin in two strains of rat.
AUTOR(ES)
Reinhard, M K
RESUMO
To provide insight into polyaspartic acid nephroprotection and differences in aminoglycoside renal toxicity between two rat strains, the single-dose pharmacokinetics of tobramycin was examined in the presence and absence of polyaspartic acid. Following a single subcutaneous 6.5-mg/kg dose of tobramycin alone, higher aminoglycoside concentrations were measured in Sprague-Dawley rats than in Fischer rats (P < 0.05). Simultaneous administration of polyaspartic acid (50 mg/kg) and tobramycin did not alter the concentrations of tobramycin in serum. The amount of tobramycin in renal tissue and the amount recovered in urine over a 24-h period were greater in both rat strains when tobramycin and polyaspartic acid were given concomitantly. In summary, polyaspartic acid did not alter the concentrations in serum achieved after a single dose of tobramycin in two different rat strains but did result in higher renal concentrations and greater urinary excretion of tobramycin.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=284400Documentos Relacionados
- Effect of polyaspartic acid on pharmacokinetics of gentamicin after single intravenous dose in the dog.
- Effects of thymectomy on bone growth in the rat.
- Comparative effects of cholestanol and cholesterol on hepatic sterol and bile acid metabolism in the rat.
- Effects of age on aneural regeneration of soleus muscle in rat.
- The effects of chronic hypoxia on renal function in the rat.
